Chloe Cole

Rallies In October 2022, Cole was among a number of speakers at a "Rally to End Child Mutilation" hosted by right-wing commentator Matt Walsh in Nashville.

In January 2023, Cole was one of five panelists who spoke at an event titled "Stolen Innocence: A Panel on the Insidious Ideology Infecting Your Children's Education", about schools allegedly sexually grooming students by teaching them about gender identity and sexual orientation. Eventbrite reportedly unpublished the listing due to violating their policies on "Hateful, Dangerous, or Violent Content and Events".

Later that month, Cole headlined a Detransition Awareness Day rally in Sacramento, CA. Roughly 40 people gathered in opposition to gender-affirming care. Nearby, counter-protesters gathered.

On April 17, 2023, Cole spoke along with Dr. Carrie Mendoza at an event at Dartmouth College. Cole said that she believed that children were too young to make "lasting medical decisions", adding that "if you are a fully grown adult … and completely understand the consequences, yes, I support you getting that surgery."

On December 4, 2024, Cole spoke at a rally to oppose gender-affirming care organized by Do No Harm outside the Supreme Court of the United States during the oral arguments for United States v. Skrmetti, which determined in June 2025 that bans on gender-affirming care for minors are constitutional.

Platform In mid-July 2022, she started a GoFundMe called "Imperfectly Me", aimed at providing a platform for detransitioners.

Lawsuit

On November 9, 2022, Cole filed a 90-day notice of intent to sue against the healthcare company Kaiser Permanente along with the individual endocrinologist, psychiatrist, and plastic surgeon involved in her treatment. Cole was represented by Harmeet Dhillon (the chief executive of the Center for American Liberty) and the law firm LiMandri & Jonna LLP. The lawsuit was filed in the San Joaquin County Superior Court in Manteca on February 22, 2023. Kaiser Permanente attempted to move the case into arbitration behind closed doors, but in September 2025 the California Courts of Appeal ruled that the case should go to trial. The trial is scheduled for April 5, 2027.

According to the lawsuit, Cole's care included "off label" treatment and "amounted to medical experimentation." According to the suit, Cole was not given adequate information to provide informed consent to her hormone therapy and later developed joint pain, osteoporosis, and ongoing urinary tract infections. The complaint states that doctors did not inform her parents of alternative, less invasive treatments like psychiatric care, and that they told her that her gender dysphoria would "never resolve unless she chemically and surgically transitioned," and subjected the family to intense pressure by falsely warning that Cole was at high risk of suicide unless she transitioned, presenting transition as the only option, and giving her parents the ultimatum: "would you rather have a dead daughter or a live son?" According to the suit, this "unethical form of coercion" backed the family "into a corner" with "no option but to continue moving forward with transition and surgery." The case is the second known lawsuit filed in the United States on this topic; Camille Kiefel, a 32-year-old woman, filed a similar case in Multnomah County, Oregon, in 2022.

The San Francisco Chronicle described Cole's case as a "political touchstone for conservative groups pushing against transgender rights and access to gender-affirming care for young people." The Economist opined that, should detransitioning lawsuits such as Cole's be successful, insurers could come to regard gender transition treatments as a liability, which would raise the treatment costs and make providers more careful about advertising; it added that, if the facts of the case were as claimed, that could cause rethinking of how care is currently provided.